Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

IMMATURITY OF THE NEWBORN RAT'S HEPATIC EXCRETORY FUNCTION FOR OUABAIN

CURTIS D. KLAASSEN
Journal of Pharmacology and Experimental Therapeutics December 1972, 183 (3) 520-526;
CURTIS D. KLAASSEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The 24-hour LD50 of ouabain in six-week-old rats is approximately 125 mg/kg while ouabain is about 40 times more toxic in 3-day-old rats (3.4 mg/kg). There was a gradual increase in the LD50 from 3 to 12 days of age and a marked increase in the LD50 between 12 and 21 days. After 30 days of age, the LD50 values remained relatively constant. In an attempt to determine the mechanism of the increased sensitivity of the newborn rat to the toxic action of ouabain, the distribution of 3H after the administration of 3H-ouabain (4 mg/kg i.p.) was measured in 7- and 39-day-old rats. The plasma concentration of ouabain was approximately 0.7 µg/ml in the 39-day-old rats and much higher in the 7-day-old rats (5.0 µg/ml). The concentration of ouabain in the liver of the 7-day-old rat was much lower (4 µg/g) than in the liver of the 39-day-old rat (20 µg/g). This increase in the capacity of the liver of the rat to concentrate ouabain and the fall in the plasma ouabain concentration also occurred between 12 and 21 days of age. Therefore, it appears that this inability of the liver of the newborn rat to concentrate ouabain over the plasma results in a higher plasma concentration of ouabain in the newborn rat and a higher toxicity. Thus, it has been demonstrated that the immaturity of the hepatic excretory mechanism is another factor why drugs are more toxic in newborn than adult rats.

Footnotes

    • Received June 7, 1972.
    • Accepted July 26, 1972.
  • © 1972 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 183, Issue 3
1 Dec 1972
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
IMMATURITY OF THE NEWBORN RAT'S HEPATIC EXCRETORY FUNCTION FOR OUABAIN
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

IMMATURITY OF THE NEWBORN RAT'S HEPATIC EXCRETORY FUNCTION FOR OUABAIN

CURTIS D. KLAASSEN
Journal of Pharmacology and Experimental Therapeutics December 1, 1972, 183 (3) 520-526;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

IMMATURITY OF THE NEWBORN RAT'S HEPATIC EXCRETORY FUNCTION FOR OUABAIN

CURTIS D. KLAASSEN
Journal of Pharmacology and Experimental Therapeutics December 1, 1972, 183 (3) 520-526;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Meeting Report for the ASPET–Ray Fuller Symposium: Cellular Mechanisms and Novel Strategies for Pain Control
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics